RWPA
ELV icon

Richard W. Paul & Associates’s Elevance Health ELV Stock Holding History

Richard W. Paul & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-640
Closed -$279K – 511
2023
Q3 		$279K Sell
640
-12
-2% -$5.44K 0.13% 146
2023
Q2 		$290K Buy
652
+3
+0.5% +$1.38K 0.13% 152
2023
Q1 		$298K Buy
+649
New +$309K 0.14% 150

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Richard W. Paul & Associates's ELV Position: Q4 2023 in Review

Richard W. Paul & Associates sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 640 shares — an estimated $279K sold.

Richard W. Paul & Associates first reported a position in ELV in Q1 2023 and held it in 3 quarters. The position peaked at $298K in Q1 2023. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

  • Richard W. Paul & Associates reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
  • Richard W. Paul & Associates sold 640 Elevance Health shares in Q4 2023, an estimated $279K.
  • Richard W. Paul & Associates first reported a position in Elevance Health in Q1 2023 and held it in 3 quarters.
  • Richard W. Paul & Associates's Elevance Health position peaked at $298K in Q1 2023.
  • 1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Richard W. Paul & Associates's 13F filing for Q4 2023, filed 23 Jan 2024.